The text mining of patents and patent applications for chemical structures of interest to medicinal chemists poses a number of unique challenges not encountered in other fields of text analytics. Traditional text mining relies on the co-occurrence of common terms between documents to provide similarity measures that can be used to cluster and rank related documents. The more words shared between two documents, the more similar they are, and the greater the probability that they discuss the same topic. By contrast, in pharmaceutical "composition of matter" patents the novel and unique chemical entities are far more significant than those that can be found elsewhere. Although the text of a pharmaceutical patent may explicitly name thousands of individual compounds, and via generic Markush structures claim an infinite number, the role of these patents is to protect the intellectual property of only one or perhaps two drug candidates.

In this work, we present an analysis of the "quality not quantity" of structures extracted by automatic Chemical Named Entity Recognition (CNER) methods both on a small hand-curated benchmark set \[[@B1]\] and a large-scale analysis of a comprehensive database of 12 million patents \[[@B2],[@B3]\]. Our results show the limited value of traditional lexicon/dictionary based approaches in extracting "key" compounds and that the major impediment is not the performance of the name-to-structure software used, but the high rate of OCR errors, typos and lexicographic problems found in patent-office data feeds. To address this problem, novel algorithms for automatic chemical spelling correction have been developed, that take advantage of the grammar used in IUPAC-like nomenclature. This forms a preprocessing pass, independent of the name-to-structure software used, and is shown to greatly improve results in our study.
